PEGylated Protamine Letrozole Nanoparticles: A Promising Strategy to Combat Human Breast Cancer via MCF-7 Cell Lines

The objective of the study was to develop PEGylated protamine letrozole nanoparticles to combat human breast cancer by modifying the release pattern of letrozole. Breast cancer is amongst the most prevalent diseases in women due to overactivity of human epidermal growth factor receptor 2 (HER2). PEG...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Muhammad Tafhim, Uddin, Zia, Javed, Muhammad Arslan, Shah, Nabi, Bashir, Hamid, Shaikh, Ahson Jabbar, Rajoka, Muhammad Shahid Riaz, Amirzada, Muhammad Imran, Asad, Muhammad Hassham Hassan Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205697/
https://www.ncbi.nlm.nih.gov/pubmed/35722457
http://dx.doi.org/10.1155/2022/4438518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205697/
https://www.ncbi.nlm.nih.gov/pubmed/35722457
http://dx.doi.org/10.1155/2022/4438518

Ejemplares similares